Arcus Biosciences, Inc.Arcus Biosciences, Inc.Arcus Biosciences, Inc.

Arcus Biosciences, Inc.

No trades
No trades

Fundamentals and stats

EPS and revenue snapshot

In the last quarter, the company reported −0.72 USD per share, beating the −0.89 USD estimate by 19.21%. Revenue for the same period reached ‪41.00 M‬ USD, despite the estimate of ‪21.98 M‬ USD. For the next quarter, analysts expect −0.88 USD in earnings per share and ‪11.14 M‬ USD in revenue.

Next report date—
Report period—
EPS estimate—
Revenue estimate—
EPS
Reported
Estimate
Metrics
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Metrics
Reported
Estimate
Surprise